CERS Related Company Press Releases
-
Cerus Corporation Reports First Quarter 2013 Results
-
Cerus Announces FDA Agreement on Modular Premarket Approval (PMA) Application Submission Process for INTERCEPT Platelets
-
Cerus to Release First Quarter 2013 Results on April 30, 2013
-
Swissmedic and Swiss Red Cross Present National Haemovigilance Data Showing Favourable Safety Profile for INTERCEPT-Treated Platelet Components
Back to CERS Stock Lookup
